Michael Buschmann, PhD, joins the Bioengineering Department as chair and full professor. Dr. Buschmann comes to Mason with over 20 years of experience at École Polytechnique in Montreal. His selection as the next chair of Bioengineering resulted from a highly competitive and rigorous recruitment process. Dr. Buschmann is a world-class researcher who has made fundamental and translational contributions to the fields of biomechanics, biomaterials, and nanomedicine. Dr. Buschmann’s recruitment was facilitated by an Eminent Scholar award from Virginia’s Center for Innovative Technology (CIT) with a total value of $500K, including matching funds from Inova Health System and the Volgenau School of Engineering. With his considerable experience in research, teaching, and entrepreneurship, Dr. Buschmann will no doubt lead Mason Bioengineering to even higher levels of excellence.
Dr. Buschmann earned his PhD in 1992 in Medical Engineering and Medical Physics from the Massuchusetts Institute of Technology in the Harvard-MIT Division of Health Sciences and Technology and conducted his postdoctoral studies at the ME Mueller Institute of Biomechanics, University of Bern, Switzerland. He became a faculty member at École Polytechnique in 1994, becoming a full professor in 2001. His research achievements are impressive, with over 150 peer-reviewed articles, over 330 conference proceedings, 5 book chapters, over 75 invited presentations, 19 patent applications (7 granted), over 12,000 citations, and an h-index of 56. He has graduated 20 PhD students, 17 MSc students, and supervised 14 postdoctoral fellows. During his academic career at École Polytechnique, he obtained over $50M in external research funding as principal investigator.
Dr. Buschmann’s research work has been recognized by 19 prizes/awards and his abilities as an educator have earned him 6 teaching awards at École Polytechnique. Dr. Buschmann has received numerous awards for his research, including the prestigious Canada Research Chair Tier 1 in 2001, the Melville Medal of the American Society of Mechanical Engineering (ASME) in 1997, and Article of the Year for ASME Journal of Biomedical Engineering in 1996. He has been the driving force behind four biotech startup companies as founder or principal inventor: Biosyntech Inc., sold to Smith & Nephew; Biomomentum Inc.; ANRis Pharma; and Ortho Regerative Technologies Inc.
Dr. Buschmann is joined at Mason by his wife, Caroline Hoemann, PhD, who is coming as a full professor in the Department of Bioengineering. Dr. Hoemann is an internationally recognized bioengineer specializing in cartilage and bone tissue engineering, and biomaterial-induced blood and innate immune responses. She brings a wealth of knowledge and experience in both academia and the biotech industry, and will strengthen Bioengineering’s research and teaching programs.